NIRMAN Stock Overview
Nirman Agri Genetics Limited operates as an agri-input company in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Nirman Agri Genetics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹220.95 |
| 52 Week High | ₹324.95 |
| 52 Week Low | ₹70.45 |
| Beta | 0 |
| 1 Month Change | 10.95% |
| 3 Month Change | -26.41% |
| 1 Year Change | 201.84% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 118.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| NIRMAN | IN Biotechs | IN Market | |
|---|---|---|---|
| 7D | 6.5% | 9.3% | 1.8% |
| 1Y | 201.8% | 24.1% | 46.4% |
Return vs Industry: NIRMAN exceeded the Indian Biotechs industry which returned 20.2% over the past year.
Return vs Market: NIRMAN exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
| NIRMAN volatility | |
|---|---|
| NIRMAN Average Weekly Movement | 9.8% |
| Biotechs Industry Average Movement | 6.1% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: NIRMAN's share price has been volatile over the past 3 months.
Volatility Over Time: NIRMAN's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 7 | Pranav Bagal | www.nirmanagrigen.com |
Nirman Agri Genetics Limited operates as an agri-input company in India. The company engages in the production, processing, and marketing of hybrid seeds, pesticides, and bio-organics for various crops comprising corn, sunflower, cotton, paddy, grain sorghum, etc. It also produces non-hybrid seeds primarily for paddy. The company was founded in 2018 and is based in Nashik, India.
Nirman Agri Genetics Limited Fundamentals Summary
| NIRMAN fundamental statistics | |
|---|---|
| Market cap | ₹1.32b |
| Earnings (TTM) | ₹40.05m |
| Revenue (TTM) | ₹286.08m |
32.9x
P/E Ratio4.6x
P/S RatioIs NIRMAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NIRMAN income statement (TTM) | |
|---|---|
| Revenue | ₹286.08m |
| Cost of Revenue | ₹226.49m |
| Gross Profit | ₹59.59m |
| Other Expenses | ₹19.54m |
| Earnings | ₹40.05m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.72 |
| Gross Margin | 20.83% |
| Net Profit Margin | 14.00% |
| Debt/Equity Ratio | 2.8% |
How did NIRMAN perform over the long term?
See historical performance and comparison